Back
Aclaris Therapeutics Vs. Triumph Financial Industry Stock Comparison
Buy
55
ACRS
Aclaris Therapeutics
Last Price:
1.15
Seasonality Move:
-1.89%
Buy
58
TFIN
Triumph Financial
Last Price:
81.91
Seasonality Move:
12.89%
Buy
55
Aclaris Therapeutics (ACRS)
is a Buy
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.21. The Score for ACRS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ACRS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Triumph Financial (TFIN)
is a Buy
Is Triumph Financial a Buy, Sell or Hold?
- The current Triumph Financial [TFIN] share price is $84.00. The Score for TFIN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- TFIN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACRS is experiencing buying pressure, which is a positive indicator for future bullish movement.
TFIN Stock Price Chart
What is Triumph Financial's stock price today?
-
The Triumph Financial share price today is $84.00
The current trend is relatively stagnant and TFIN is experiencing slight buying pressure.
ACRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 53.05 | Buy |
| Chaikin Money Flow: | 149721 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.16 - 1.22) | Buy |
| Bollinger Bands (100): | (1.11 - 1.29) | Buy |
TFIN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 55.71 | Buy |
| Chaikin Money Flow: | 7911 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (80.08 - 84.4) | Buy |
| Bollinger Bands (100): | (74.22 - 85.72) | Buy |
ACRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.18 | Buy |
| 20-day SMA: | 1.18 | Buy |
| 50-day SMA: | 1.24 | Sell |
| 200-day SMA: | 1.18 | Buy |
| 8-day EMA: | 1.19 | Buy |
| 20-day EMA: | 1.19 | Buy |
| 50-day EMA: | 1.21 | Buy |
| 200-day EMA: | 2.1 | Sell |
TFIN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 81.05 | Buy |
| 20-day SMA: | 81.83 | Buy |
| 50-day SMA: | 84.35 | Sell |
| 200-day SMA: | 77.64 | Buy |
| 8-day EMA: | 81.92 | Buy |
| 20-day EMA: | 81.88 | Buy |
| 50-day EMA: | 82.09 | Buy |
| 200-day EMA: | 77.17 | Buy |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.13 per share, an increase this year of $1.08 per share, and a decrease next year of $0.09 per share.
Triumph Financial Earnings Growth & TFIN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.37 per share, a decrease this year of $0.90 per share, and an increase next year of $1.31 per share.
Aclaris Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Triumph Financial Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||